Position in VTRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,687,944
-$3,462,726 QoQ
Shares Held
169,266
-62.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $73,921,281 across 21 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
104,854 | $17,672,092 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
484,342 | $16,409,506 | |
| 3 | ZTS |
Zoetis Inc.
|
213,961 | $15,375,236 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
26,181 | $14,185,650 | |
| 5 | VTRS |
Viatris Inc
This page
|
169,266 | $2,687,944 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
56,705 | $1,395,510 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
211,124 | $1,040,841 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
21,928 | $793,793 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,687,944 | 169,266 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $6,150,670 | 455,268 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,774,014 | 383,455 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,954,585 | 197,433 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $265,542 | 29,736 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $11,619,549 | 1,334,047 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $16,937,552 | 1,360,446 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,074,311 | 1,384,523 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,776,581 | 1,390,083 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $17,453,199 | 1,461,742 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $16,091,365 | 1,485,814 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $14,763,051 | 1,497,267 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,777,323 | 1,280,293 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $12,122,074 | 1,260,091 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $7,991,673 | 718,030 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,850,930 | 686,729 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $7,325,502 | 699,666 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $6,757,425 | 621,087 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,840,001 | 653,363 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $9,934,547 | 733,177 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,352,703 | 794,451 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $11,998,286 | 858,861 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $19,293,671 | 1,029,545 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||